Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P14784 (
IL-2 receptor
)
3,849
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
CD8 memory T cells are enriched in the bone marrow, a site where these cells are thought to receive homeostatic signals. However, the primary site where CD8 memory T cells receive their cytokine-induced homeostatic signals has recently come under debate. In this study, we demonstrate that the bone marrow contains a fraction of CD8 memory phenotype T cells with elevated expression of
glucocorticoid-induced TNFR-related protein
(
GITR
). In contrast, splenic and lymph node memory phenotype T cells have
GITR
levels similar to those on naive T cells. The bone marrow
GITR
(hi) memory T cells have a phenotype indicative of cytokine activation, with higher
CD122
and lower CD127 than do the
GITR
(basal) memory T cells. Remarkably, these bone marrow-specific
GITR
(hi) cells are almost completely ablated in the absence of IL-15, whereas TNFR2 and 4-1BB expression on the CD8 memory T cells are IL-15 independent. Furthermore, adoptively transferred splenic CD8 memory phenotype T cells show IL-15-dependent
GITR
upregulation upon entry into the bone marrow. This result implies that the selective appearance of
GITR
(hi) memory phenotype T cells in the bone marrow reflects the local microenvironment rather than a different subset of memory T cells.
GITR
(-/-) mice have a lower frequency of CD8 memory phenotype cells in the bone marrow, yet the
GITR
(-/-) cells hyperproliferate compared with those in wild-type mice. Taken together, these data suggest that
GITR
plays a role in the survival of CD8 memory phenotype T cells and that
GITR
upregulation represents a precise marker of cells that have responded to IL-15.
...
PMID:IL-15-dependent upregulation of GITR on CD8 memory phenotype T cells in the bone marrow relative to spleen and lymph node suggests the bone marrow as a site of superior bioavailability of IL-15. 2258 58